Interleukin 33 regulates the autophagy of oxygen-glucose-deprivation/reoxygenation microglia via macrophage polarization
More details
Hide details
1
Central Laboratory, Affiliated Fuzhou First Hospital of Fujian Medical University, Fuzhou, Fujian, 350009, China
2
College of Life Sciences, Fujian Normal University, Fuzhou, Fujian, 350009, China
3
Department of Neurosurgery, Affiliated Fuzhou First Hospital of Fujian Medical University, Fuzhou, Fujian, 350009, China
4
Department of Respiratory Medicine, Affiliated Fuzhou First Hospital of Fujian Medical University, Fuzhou, Fujian, 350009, China
These authors had equal contribution to this work
Submission date: 2024-05-05
Final revision date: 2025-04-03
Acceptance date: 2025-04-10
Online publication date: 2026-01-23
Corresponding author
Yongkai Yang
Department of Neurosurgery, Affiliated Fuzhou First Hospital of Fujian Medical University, Fuzhou, Fujian, 350009, China
KEYWORDS
ABSTRACT
Introduction:
Interleukin (IL)-33 is a pleiotropic cytokine in the immune system and inflammatory responses, which is involved in cerebral ischemia/reperfusion (I/R) injury. Evidence indicates that IL-33 plays an essential role in macrophage polarization activation, yet the potential molecular mechanisms remain elusive. This study explored the role of IL-33 in the activation of microglia/macrophage-mediated autophagy for cerebral I/R injury via in vitro experiments.
Material and Methods:
Primary macrophages were harvested from mouse bone marrow, and microglia were isolated from mouse brains. Lipopolysaccharide (LPS) and interferon (IFN-) induced polarization toward the M1 phenotype macrophage, and IL-4 induced polarization toward the M2 phenotype macrophage. Oxygen glucose deprivation/reoxygenation (OGD/R) models of primary microglia were established and co-cultured with M1 and M2 macrophages, respectively. The IL-33 knockout microglia OGD/R model and M1/M2 macrophages were co-cultured to explore the effects of IL-33 in the transformation from pro-inflammatory (M1) phenotype to anti-inflammatory (M2) phenotype against inflammation and autophagy. Microglial activation/polarization, autophagy, and inflammation were detected using western blot, immunofluorescence, and ELISA.
Results:
Compared with microglia co-cultured with M1 macrophages, microglia co-cultured with M2 macrophages showed significantly higher expression of M2 intracellular markers (STAT6, PPAR-, IRF4, CEBP-, and CD206 (p < 0.05). In contrast, the expression of STAT1 and IRF8 was significantly lower. IL-33 deficiency enhanced the anti-inflammatory phenotype of microglia/M2 macrophages. Furthermore, the expression of IL-10 and transforming growth factor (TGF-) was upregulated (p < 0.05), and the expression of IFN- was downregulated (p < 0.05) in microglia/M2 macrophages in comparison with microglia/M1 macrophages. Compared with the OGD/R model group, M1 macrophage co-culture increased Beclin-1 and ULK1 expression and reduced P62 expression, and M2 co-culture as well as IL-33 deletion reduced Beclin-1 and ULK1 expression and increased P62 expression levels.
Conclusions:
IL-33 deficiency inhibited hypoxia-induced microglia autophagy and promoted macrophage polarization toward the anti-inflammatory phenotype.
REFERENCES (23)
1.
Ding W, Gu Q, Liu M, et al. (2023): Astrocytes-derived exosomes pre-treated by berberine inhibit neuroinflammation after stroke via miR-182-5p/Rac1 pathway. Int Immunopharmacol 2023; 118: 110047.
2.
Zhang X, Zhu XL, Ji BY, et al. (2019): LncRNA-1810034E14Rik reduces microglia activation in experimental ischemic stroke. J Neuroinflammation 16: 75.
3.
Wang S, Zhang H, Xu Y (2016): Crosstalk between microglia and T cells contributes to brain damage and recovery after ischemic stroke. Neurol Res 38: 495-503.
4.
Filomeni G, De Zio D, Cecconi F (2015): Oxidative stress and autophagy: the clash between damage and metabolic needs. Cell Death Differ 22: 377-388.
5.
Jiang CT, Wu WF, Deng YH, Ge JW (2020): Modulators of microglia activation and polarization in ischemic stroke (Review). Mol Med Rep 21: 2006-2018.
6.
He J, Liu J, Huang Y, et al. (2021): Oxidative stress, inflammation, and autophagy: potential targets of mesenchymal stem cells-based therapies in ischemic stroke. Front Neurosci 15: 641157.
7.
Wu MY, Yiang GT, Liao WT, et al. (2018): Current mechanistic concepts in ischemia and reperfusion injury. Cell Physiol Biochem 46: 1650-1667.
8.
Loane DJ, Kumar A (2016): Microglia in the TBI brain: The good, the bad, and the dysregulated. Exp Neurol 275 Pt 3 (0 3): 316-327.
9.
Cui W, Hao Y, Wang M, et al. (2022): Inhibition of autophagy facilitates XY03-EA-mediated neuroprotection against the cerebral ischemia/reperfusion injury in rats. Oxid Med Cell Longev 2022: 7013299.
10.
Abd Rachman Isnadi MF, Chin VK, Abd Majid R, et al. (2018): Critical roles of IL-33/ST2 pathway in neurological disorders. Mediators Inflamm 2018: 5346413.
11.
Cao K, Liao X, Lu J, et al. (2018): IL-33/ST2 plays a critical role in endothelial cell activation and microglia-mediated neuroinflammation modulation. J Neuroinflammation 15: 136.
12.
Dickinson JD, Alevy Y, Malvin NP, et al. (2016): IL13 activates autophagy to regulate secretion in airway epithelial cells. Autophagy 12: 397-409.
13.
Mijajlovic MD, Aleksic VM, Sternic NM, et al. (2017): Role of prediabetes in stroke. Neuropsychiatr Dis Treat 13: 259-267.
14.
David S, Kroner A (2011): Repertoire of microglial and macrophage responses after spinal cord injury. Nat Rev Neurosci 12: 388-399.
15.
Suenaga J, Hu X, Pu H, et al. (2015): White matter injury and microglia/macrophage polarization are strongly linked with age-related long-term deficits in neurological function after stroke. Exp Neurol 272: 109-119.
16.
Zhang H, Lu M, Zhang X, et al. (2019): Isosteviol sodium protects against ischemic stroke by modulating microglia/macrophage polarization via disruption of GAS5/miR-146a-5p sponge. Sci Rep 9: 12221.
17.
Zhang H, Zhang T, Wang D, et al. (2020): IFN- regulates the transformation of microglia into dendritic-like cells via the ERK/c-myc signaling pathway during cerebral ischemia/reperfusion in mice. Neurochem Int 141: 104860.
18.
Spera PA, Ellison JA, Feuerstein GZ, Barone FC (1998): IL-10 reduces rat brain injury following focal stroke. Neurosci Lett 251: 189-192.
19.
Ooboshi H, Ibayashi S, Shichita T, et al. (2005): Postischemic gene transfer of interleukin-10 protects against both focal and global brain ischemia. Circulation 111: 913-919.
20.
Han R, Lan X, Han Z, et al. (2023): Improving outcomes in intracerebral hemorrhage through microglia/macrophage-targeted IL-10 delivery with phosphatidylserine liposomes. Biomaterials 301: 122277.
21.
Gabryelska A, Kuna P, Antczak A, et al. (2019): IL-33 mediated inflammation in chronic respiratory diseases-understanding the role of the member of IL-1 superfamily. Front Immunol 10: 692.
22.
Yasuoka S, Kawanokuchi J, Parajuli B, et al. (2011): Production and functions of IL-33 in the central nervous system. Brain Res 1385: 8-17.
23.
Yuanyuan Y, Huan L, Haiyue Z, et al. (2017): ST2/IL-33-dependent microglial response limits acute ischemic brain injury. J Neurosci 37: 4692-4704.